午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

TargetMol中國（陶術(shù)生物） Company Information
Company Name:    TargetMol Chemicals Inc.
Tel:    -
Email:    marketing@targetmol.cn
Nationality:    China
WebSite:    https://www.targetmol.cn/
Product List:    24571
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179
Product List
Fadrozole HCl hydrate 176702-70-8
DS-6930 1242328-82-0
BI-10 2759037-58-4
IXA6 1021106-40-0
ZINC09659342 1668604-47-4
MK-8153 1548286-45-8
18-Deoxyherboxidiene 1200128-66-0
Methyl 3-(3-bromophenyl)-1,2-oxazole-5-carboxylate 377059-68-2
(15aS)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine 486429-95-2
Clevudine triphosphate 174625-00-4
MCT1-IN-3 2878360-80-4
(15aR)-1,15-Bis(diphenylphosphino)-7,8,9,10-tetrahydro-6H-dibenzo[b,d][1,6]dioxacycloundecine 301847-91-6
Rociclovir PM 89419-23-8
Oxepinac 55689-65-1
Losulazine 72141-57-2
Minamestane 105051-87-4
BTA-188 314062-80-1
Duocarmycin analog-2 1164275-01-7
DG013A 2007955-07-7
BRL-15572 hydrochloride 1173022-77-9
Glyoxalase I inhibitor 2 2314467-61-1
Tubulin inhibitor 23 170488-57-0
GNF2133 hydrochloride 2561414-57-9
Edecesertib 2408839-73-4
Penamecillin 983-85-7
Darglitazone Sodium 149904-87-0
Vinaxanthone 133293-89-7
Annamycin 92689-49-1
Ciproquazone 33453-23-5
Safironil 134377-69-8
ALDH2 modulator 1 1629615-99-1
Pipoxizine 55837-21-3
Elbanizine 110629-41-9
HAMI 3379 1245653-57-9
Efpeglenatide 1296200-77-5
Regorafenib mesylate 835621-08-4
Pafenolol 75949-61-0
ABC44 1831135-46-6
Tampramine 83166-17-0
PND-1186 hydrochloride 1356154-94-3
Bafrekalant 2256770-44-0
PTP1B-IN-15 765317-71-3
Ontazolast 147432-77-7
Epitinib 1203902-67-3
UNC4203 1818234-19-3
BMS-566419 566161-24-8
Xanthine amine congener hydrochloride 1783977-95-6
CDK5-IN-2 2639542-22-4
NDB 1660153-08-1
RIPK3-IN-1 2361139-70-8
EHT 5372 1425945-63-6
CB1R antagonist 1 334668-69-8
CJ-2360 2226742-61-4
BSJ-01-175 2227392-55-2
Laniquidar 197509-46-9
Mytoxin B 105049-15-8
ST247 1356497-91-0
SARS-CoV-2 nsp13-IN-1 1005304-44-8
BACE-IN-1 1254166-60-3
Inaperisone 99323-21-4
Nrf2 activator-4 2383016-68-8
TXA6101 1459695-66-9
Quinine hydrobromide 549-49-5
ML138 1355243-24-1
Vamotinib 1416241-23-0
SMO-IN-3 2376914-71-3
GSK2647544 1380426-95-8
10-Formyl-5,8-dideazafolic acid 61038-31-1
Tazomeline 131987-54-7
Saterinone 102669-89-6
Solpecainol 155321-96-3
Camonagrel 105920-77-2
GS-6620 PM 1191237-49-6
PI3K/mTOR Inhibitor-4 2361215-32-7
UCB7362 2610631-17-7
Sovesudil 1333400-14-8
ITK inhibitor 6 2404604-06-2
NF-κB/MAPK-IN-1 2413940-56-2
BS-181 dihydrochloride 1883548-83-1
MK-6186 1034474-19-5
CQ211 2648986-65-4
Tau-aggregation and neuroinflammation-IN-1 2175953-98-5
HIV-1 inhibitor-31 920036-04-0
DDO-02005 1186049-44-4
ONO-9780307 856691-44-6
Nezulcitinib 2412496-23-0
Tiflucarbine 89875-86-5
CSF1R-IN-3 2760584-90-3
(16aR)-1,16-Bis(diphenylphosphino)-6,7,8,9,10,11-hexahydrodibenzo[b,d][1,6]dioxacyclododecine 301847-92-7
CCT369260 2647503-57-7
HTT-D3 2254502-89-9
Tripelennamine citrate 6138-56-3
A2A receptor antagonist 3 2738606-83-0
Glucametacine 52443-21-7
UCM-1306 2258608-78-3
(Rac)-Norcisapride 84946-16-7
4,4'-(Triaz-1-ene-1,3-diyl)dibenzimidamide hydrochloride 2331268-15-4
Ezurpimtrostat hydrochloride 1914148-73-4
Paltimatrectinib 2353522-15-1
Org 43553 501444-88-8
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179
Copyright 2007©  ChemicalBook. All rights reserved.